One of the therapeutic goals in ankylosing spondylitis is to reduce spinal ankylosing progression. Data from the AxSpA cohort SCQM provide further evidence regarding the efficacy of TNF inhibitors.
One of the therapeutic goals in ankylosing spondylitis is to reduce spinal ankylosing progression. Data from the AxSpA cohort SCQM provide further evidence regarding the efficacy of TNF inhibitors.
Input your search keywords and press Enter.